Stephan R. Vavricka

25.3k total citations · 4 hit papers
240 papers, 11.0k citations indexed

About

Stephan R. Vavricka is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Stephan R. Vavricka has authored 240 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Genetics, 119 papers in Epidemiology and 78 papers in Surgery. Recurrent topics in Stephan R. Vavricka's work include Inflammatory Bowel Disease (129 papers), Microscopic Colitis (95 papers) and Eosinophilic Esophagitis (29 papers). Stephan R. Vavricka is often cited by papers focused on Inflammatory Bowel Disease (129 papers), Microscopic Colitis (95 papers) and Eosinophilic Esophagitis (29 papers). Stephan R. Vavricka collaborates with scholars based in Switzerland, United States and Germany. Stephan R. Vavricka's co-authors include Gerhard Rogler, Alain Schoepfer, Michael Scharl, Thomas Greuter, Luc Biedermann, Alex Straumann, Michael Fried, Jonas Zeitz, Valérie Pittet and Christoph Beglinger and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Stephan R. Vavricka

229 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Environmental triggers in IBD: a review of progress and evidence

2017 662 citations Andrew J. Macpherson, Stephan R. Vavricka et al. profile →
Extraintestinal Manifestations of Inflammatory Bowel Disease

2015 515 citations Stephan R. Vavricka, Alain Schoepfer et al. Inflammatory Bowel Diseases profile →
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations

2016 506 citations Paolo Gionchetti, Axel Dignaß et al. Journal of Crohn s and Colitis profile →
European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases

2014 421 citations Axel Dignaß, Silvio Danese et al. Journal of Crohn s and Colitis profile →

Peers

Countries citing papers authored by Stephan R. Vavricka

Since Specialization

Citations

This map shows the geographic impact of Stephan R. Vavricka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan R. Vavricka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan R. Vavricka more than expected).

Fields of papers citing papers by Stephan R. Vavricka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan R. Vavricka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan R. Vavricka. The network helps show where Stephan R. Vavricka may publish in the future.

Co-authorship network of co-authors of Stephan R. Vavricka

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan R. Vavricka. A scholar is included among the top collaborators of Stephan R. Vavricka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan R. Vavricka. Stephan R. Vavricka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ECCO Topical Review on Pouch Disorders 2025 ·Journal of Crohn s and Colitis ·Maia Kayal, Gabriele Bislenghi, Michel Adamina, Zaid Ardalan, (unknown), Anthony de Buck van Overstraeten, Marjolijn Duijvestein, María Manuela Estevinho, Federica Furfaro, Ailsa Hart, Stefan D. Holubar, Triana Lobatón, Jacob E. Ollech, Stephan R. Vavricka, Mark A. Ferrante	0
2	Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice 2023 ·Swiss Medical Weekly ·(unknown), Christoph Matter, Emanuel Burri, Tatiana Galpérine, Petr Hrúz, Pascal Juillerat, Alain Schoepfer, Stephan R. Vavricka, (unknown), (unknown), Frank Seibold	0
3	Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study 2023 ·Journal of Clinical Medicine ·Ahmad Albshesh, (unknown), (unknown), Marie Truyens, Stephan R. Vavricka, (unknown), Daniela Pugliese, Edoardo Savarino, Eran Zittan, David Drobne, Xavier Roblin, Ariella Bar‐Gil Shitrit, Alessandro Armuzzi, Triana Lobatón, Nitsan Maharshak, Henit Yanai, Shomron Ben‐Horin, Uri Kopylov	4
4	Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort study 2023 ·United European Gastroenterology Journal ·(unknown), (unknown), Johan Burisch, Elisabeth Genestin, (unknown), Oliver Nagel, Nawab Qizilbash, David A. Schwartz, Stephan R. Vavricka, Dimitri Bennett, Axel Dignaß	1
5	Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn’s disease in Europe: a retrospective observational study 2023 ·BMC Gastroenterology ·Roni Weisshof, Stephan R. Vavricka, Lieven Pouillon, (unknown), Montserrat Roset, (unknown), Marc Ferrante	0
6	Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland 2022 ·Therapeutic Advances in Gastroenterology ·(unknown), Niklas Krupka, (unknown), Jean‐Benoît Rossel, Luc Biedermann, Thomas Greuter, Philipp Schreiner, Stephan R. Vavricka, Pascal Juillerat, Emanuel Burri, Dorothee Zimmermann, Michel H. Maillard, Michael Christian Sulz, Stephan Brand, Gerhard Rogler, Benjamin Misselwitz	4
7	Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel disease 2021 ·Digestive and Liver Disease ·Paula Sousa, Paula Ministro, Alessandro Armuzzi, Axel Dignaß, Marte Lie Høivik, Manuel Barreiro‐de Acosta, Stephan R. Vavricka, Rogério Saad-Hossne, Paulo Gustavo Kotze, Laurent Peyrin‐Biroulet, Fernando Magro	4
8	Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland 2020 ·Advances in Therapy ·A Aksan, Alain Schoepfer, Pascal Juillerat, Stephan R. Vavricka, (unknown), Antonio Ramírez de Arellano, (unknown), (unknown), William J. Valentine, Barnaby Hunt	15
9	Inflammatory bowel disease in sub-Saharan Africa: a protocol of a prospective registry with a nested case–control study 2020 ·BMJ Open ·Leolin Katsidzira, (unknown), Rudo Makunike-Mutasa, Bahtiyar Yılmaz, Annika Blank, Gerhard Rogler, Andrew J. Macpherson, Stephan R. Vavricka, Innocent T. Gangaidzo, Benjamin Misselwitz	4
10	Fatigue in inflammatory bowel disease and its impact on daily activities 2020 ·Alimentary Pharmacology & Therapeutics ·Philipp Schreiner, Jean‐Benoît Rossel, Luc Biedermann, Philipp O. Valko, Christian R. Baumann, Thomas Greuter, Michael Scharl, Stephan R. Vavricka, Valérie Pittet, Pascal Juillerat, Gerhard Rogler, Roland von Känel, Benjamin Misselwitz, (unknown)	38
11	European Crohn’s and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease 2019 ·Journal of Crohn s and Colitis ·Joana Torres, Pierre Ellul, Jost Langhorst, Antonina Mikocka‐Walus, Manuel Barreiro‐de Acosta, Chamara Basnayake, Nik S. Ding, Daniela Gilardi, Κωνσταντίνος Κατσάνος, Gabriele Moser, Randi Opheim, Carolina Palmela, Gianluca Pellino, Sander van der Marel, Stephan R. Vavricka	94
12	Vegetarian or gluten‐free diets in patients with inflammatory bowel disease are associated with lower psychological well‐being and a different gut microbiota, but no beneficial effects on the course of the disease 2019 ·United European Gastroenterology Journal ·Philipp Schreiner, Bahtiyar Yılmaz, Jean‐Benoît Rossel, Yannick Franc, Benjamin Misselwitz, Michael Scharl, Jonas Zeitz, Pascal Frei, Thomas Greuter, Stephan R. Vavricka, Valérie Pittet, Alexander Siebenhüner, Pascal Juillerat, Roland von Känel, Andrew J. Macpherson, Gerhard Rogler, Luc Biedermann, (unknown)	74
13	Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study 2019 ·PLoS ONE ·(unknown), Sylvie Scharl, Stephan R. Vavricka, Gerhard Rogler, Nicolas Fournier, Valérie Pittet, Michael Scharl, Thomas Greuter, Philipp Schreiner, Pascal Frei, Benjamin Misselwitz, Luc Biedermann, Jonas Zeitz, (unknown)	6
14	Protocol for a prospective, controlled, observational study to evaluate the influence of hypoxia on healthy volunteers and patients with inflammatory bowel disease: the Altitude IBD Study 2017 ·BMJ Open ·Stephan R. Vavricka, Pedro A. Ruiz, Sylvie Scharl, Luc Biedermann, Michael Scharl, Cheryl de Vallière, (unknown), Roland H. Wenger, Leonhard Held, Tobias M. Merz, Max Gassmann, Thomas A. Lutz, Andres Kunz, (unknown), A. Fontana, Laura Strauss, Achim Weber, Michael Fried, Gerhard Rogler, Jonas Zeitz	7
15	3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations breakdown → 2016 ·Journal of Crohn s and Colitis ·Paolo Gionchetti, Axel Dignaß, Silvio Danese, (unknown), Gerhard Rogler, Péter L. Lakatos, Michel Adamina, Sandro Ardizzone, Christianne J. Buskens, Shaji Sebastian, Silvio Laureti, Gianluca M. Sampietro, Boris Vucelić, C. Janneke van der Woude, Manuel Barreiro‐de Acosta, Christian Maaser, Francisco Portela, Stephan R. Vavricka, Fernando Gomollón, (unknown)	506
16	VAlidation of an 8-item-questionnaire predictive for a positive caLprotectin tEst and Real-life implemenTation in primary care to reduce diagnostic delay in inflammatory bowel disease (ALERT): protocol for a prospective diagnostic study 2015 ·BMJ Open ·(unknown), (unknown), (unknown), Stephan R. Vavricka, Gerhard Rogler, (unknown), Thomas Rosemann	8
17	Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study 2015 ·Inflammatory Bowel Diseases ·Ekaterina Safroneeva, Stephan R. Vavricka, Nicolas Fournier, Alex Straumann, Gerhard Rogler, Alain Schoepfer	13
18	Addressing current treatment challenges in Crohn's disease in real life: A physician's survey 2014 ·Digestive and Liver Disease ·Stephan R. Vavricka, (unknown), Christine N. Manser, Pascal Frei, Emanuel Burri, Michael Fried, Alain Schoepfer, Laurent Peyrin‐Biroulet, Pierre Michetti, Gerhard Rogler, Luc Biedermann	3
19	Determination of the Single Nucleotide Polymorphisms C3435 and G2677T in MDR1 and C421A in BCRP in Blood Samples of Patients with Inflammatory Bowel Disease and Healthy Controls in the Swiss Population 2012 ·Zurich Open Repository and Archive (University of Zurich) ·(unknown), (unknown), (unknown), Gerd A. Kullak‐Ublick, Stephan R. Vavricka, (unknown), (unknown)	2
20	Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohnʼs disease population 2009 ·Inflammatory Bowel Diseases ·Alain Schoepfer, Stephan R. Vavricka, Janek Binek, Christian Felley, Martin Geyer, Markus G. Manz, Gerhard Rogler, Philippe de Saussure, Bernhard Sauter, Frank Seibold, Alex Straumann, Pierre Michetti	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact